BRK-B vs PDT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating fundamental trends. There is a significant valuation gap, with the current price of $473.01 trading at a substantial premium to the growth-based intrinsic value of $217.14. While the company maintains a fortress balance sheet with an exceptional current ratio of 7.07 and low debt/equity (0.19), negative YoY revenue and earnings growth suggest a period of stagnation. The overall outlook is tempered by a bearish technical trend and a very high PEG ratio of 10.06.
PDT exhibits a stable but stagnant financial profile, anchored by a Piotroski F-Score of 4/9 and a Graham Number of $20.92 that suggests significant defensive undervaluation. While the fund offers an attractive 7.49% dividend yield and trades at a low P/E of 9.50 relative to the sector average of 35.00, these strengths are countered by a severe -40.5% collapse in earnings growth. The technical trend is currently bearish (0/100), and the discrepancy between the Graham Number and the growth-based intrinsic value ($9.73) indicates a conflict between asset value and earning power.
Compare Another Pair
Related Comparisons
BRK-B vs PDT: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and John Hancock Premium Dividend Fund (PDT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.